San Francisco, California, United States In 2018 was created Brii Biosciences, which is appeared as Corporate Investor. The main office of represented Corporate Investor is situated in the San Francisco. The venture was found in North America in United States.
The current fund was established by Zhi Hong.
Among the various public portfolio startups of the fund, we may underline Artizan Biosciences For fund there is a match between the location of its establishment and the land of its numerous investments - United States. We can highlight the next thriving fund investment areas, such as Life Science, Biotechnology. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in 2-6 deals per year. The top activity for fund was in 2019.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Brii Biosciences, startups are often financed by Malin Corporation, Hatteras Venture Partners. The meaningful sponsors for the fund in investment in the same round are OUP (Osage University Partners), Mountain Group Capital, Marin Investments.
Related Funds
| Fund Name | Location |
| 1955 Capital | California, Los Altos, United States |
| 3K.com | - |
| Bozhong.com | China, Guangdong, Guangzhou |
| C-Mer Eye Care Holdings | China, Hong Kong, Hong Kong Island |
| Chuangzhi Capital | - |
| Connector Media | - |
| Crescendo Capital Partners | Centennial, Colorado, United States |
| Essential Capital Consortium | - |
| Nader Group | Amman, Amman, Jordan |
| NFT Ventures | Stockholm, Stockholm County, Sweden |
| Perfect World Capital | District of Columbia, United States, Washington |
| ROFEIN | - |
| Scientipole Ile-de-France Capital | France, Ile-de-France, Orsay |
| Shanghai Lindian Wangluo Keji Youxian Gongsi | China, Shanghai |
| Shenzhen Press Group | China, Guangdong, Shenzhen |
| Suzhou Chunhe Jingming Investment Center | China, Jiangsu, Suzhou |
| W&W brandpool | Baden-Wurttemberg, Germany, Stuttgart |
| Zero2IPO Ventures | Beijing, Beijing, China |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
AN2 Therapeutics | $12M | 21 Nov 2019 | California, United States | ||
Artizan Biosciences | $12M | 11 Jun 2019 | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
AN2 Therapeutics | $12M | 21 Nov 2019 | California, United States | ||
Artizan Biosciences | $12M | 11 Jun 2019 | New York, New York, United States |
